Navigation Links
Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship
Date:12/2/2008

ased capability and adaptability Sage Intergy offers, ACC will be able to:

-- Capture the data necessary to collect the 2 percent bonus that the Centers for Medicare & Medicaid Services will begin paying in 2009 to physicians who successfully e-prescribe under Medicare Part D.

-- Send friendly, customized letters to encourage patients who are uninsured or have high-deductible health plans to work out a payment plan, rather than just receiving monthly statements followed by calls from debt collectors. This allows ACC to work in a cooperative manner with patients to implement a mutually beneficial payment schedule, which will greatly enhance patient satisfaction and retention as well as improving collections.

-- Provide innovative patient- and caregiver-friendly encounter summaries to ensure that when patients leave the office they will have information about their treatment plan at their fingertips. Cardiology care is complex and many patients, especially the elderly, often are unable to remember or relay physicians' instructions to their caregiver when they get home. The encounter summary will help enhance quality of care and timely patient adherence with the prescribed course of treatment, thus improving outcomes. Additionally, it also will provide interested patients with key information to create and maintain an online personal health record, and boost practice efficiency by reducing the volume of calls from patients and their caregivers.

-- Facilitate patient recruitment for clinical trials being performed by ACC. By embedding the criteria for all its clinical trials into the EHR alert function, ACC will be able to identify candidates for clinical trials as soon as they present before a medical assistant, nurse or physician. This will dramatically improve the efficiency of the patient identification and recruitment process.

Said Sharon Howard, senior vice preside
'/>"/>

SOURCE Sage Software Healthcare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
2. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Aerospace engineer earns Oak Ridge Associated Universities Ralph Powe Junior Faculty Award
5. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
6. 3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
7. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
10. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
11. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE:...John Docherty, president and chief operating offic...ual Investor Summit on November 10, 2009 at 4:00 P...erty will provide an overview of the Company,s lea...cal Interferon Alpha-2b. The slide show portion o...
(Date:11/6/2009)...swire-FirstCall/ -- ,, 3Q09 Corporate Highli....U. Marketing Authorization to Astellas Pharma Eur... readiness activities Expanded management team to... Director, Commercial Operations Appointed Bradfo...ttee chairman , Upcoming 2009 Milestones: ...
(Date:11/6/2009)...ire/ -- Intarcia Therapeutics, Inc. delivered two ...ontinuous delivery of exenatide) program for the t...abetes Technology Meeting in San Francisco, CA: ,...050301/SFTU126LOGO ) ,, Continuous Subcutaneo...a Glucose, HbA1c and Reduces Weight in a 28-day Ph...
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...I -In recognition of the impact of Wisconsins heal...health of its citizens, Wisconsin Governor Jim Doy...chnology Recognition Week to encourage sponsorship...ation of health science and technology in Wisconsi...of two such events that will take place that week:...
... manufacturing are still going on in the Midwest a... which was featured on an NBC news story on Monday... these jobs are disappearing. , ,The consensus is...es and most stop there with their strategic analys...any companies are so focused on the bottom line. I...
...reliable market research on an ongoing basis is th...ing campaign. Nevertheless, for many companies, th...e costs of conducting marketing research always se...pensive. Not knowing your customers needs can be c...e is to go on gut instinct or apply someone elses ...
Other Biology Technology:Governor Proclaims November 1-7 Health Science and Technology Recognition Week 2Governor Proclaims November 1-7 Health Science and Technology Recognition Week 3Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4Talking Bout My Generation: The Evolution of Online Marketing Research 2Talking Bout My Generation: The Evolution of Online Marketing Research 3
(Date:11/6/2009)...150th anniversary this month of the publication of...of Biological Sciences (AIBS) is publishing open a...win and his historic insights into evolution. , T...ity of California, Berkeley, and James T. Costa of...en Myths About Charles Darwin," appeared in the Oc...
(Date:11/5/2009)...ciation of Biology Teachers (NABT) will recognize ...nces at Naugatuck Valley Community College (NVCC) ... Education Award during the NABT annual profession...r 2009 in Denver, Colorado. , The Evolution Educ...te of Biological Sciences,(AIBS) and Biological S...
(Date:11/4/2009)...ws in natural science) , United States Using L...ater today than it did 35 years ago, despite a 30 ... are partly attributable to alternative cooling me...n systems. According to the latest USGS water use ...d States goes to cooling thermoelectric power plan...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Prostate cancer patients on hormone therapy at increased risk for various heart diseases 57921 1Prostate cancer patients on hormone therapy at increased risk for various heart diseases 57921 2Prostate cancer patients on hormone therapy at increased risk for various heart diseases 57921 3Prostate cancer patients on hormone therapy at increased risk for various heart diseases 57921 4Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 57919 1Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 57919 2Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 57919 3Targeted heat therapy offers new standard treatment option for soft tissue sarcoma 57919 4Summits Alone Wont Feed the Hungry Aid Agency Says 57917 1Summits Alone Wont Feed the Hungry Aid Agency Says 57917 2
...am of scientists has solved a mystery that has puz...ered that fish contribute a significant fraction o...affects the delicate pH balance of seawater. The s...percent of marine calcium carbonate being produced...up to three times higher. , Published January 1...
...dition of the Journal of Nutrition offers new in...eeding and health outcomes related to obesity. Ac... clinical epidemiology at the University of Southa...epartment of Medicine at the Oregon Health and Sci...rt, "A longer period of breastfeeding was associat...
...ners of the National Lung Cancer Partnership/LUNGe...lli, M.D. and Lee Goodglick, Ph.D. The $100,000 gr...l pleural invasion and the role of estrogen in lun...a general thoracic surgeon specializing in lung ca...New York, was awarded the grant focused on basic r...
Other Biology News:Fishdunnit! Mystery solved 2Fishdunnit! Mystery solved 3New infant feeding and obesity research adds insight to ongoing issue 2National Lung Cancer Partnership and LUNGevity Foundation announce 2009 grant recipients 2
...hemical Inkjet Printer) is a revolutionary new app...acroarray Analysis, developed in conjunction with ...trategy compliments established protocols in resol...lectric point and apparent molecular weight). Howe...
RNase Inhibitor from Applied Biosystems
Goat Anti-Rat UGT1A7 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
Biology Products: